The use of saliva as the preferred sample in the diagnosis of SARS-CoV-2, in all group ages, determines the development of a study at the Instituto Gulbenkian de Ciência, in collaboration with Hospital Dona Estefânia and Hospital Amadora Sintra. As the first data revealed to be very promising, the study aims to optimize processes to facilitate diagnosis.

Watch TVI news story (in Portuguese) with Maria João Amorim, principal investigator at Instituto Gulbenkian de Ciência who coordinates the study.